| pubmed-article:12646688 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12646688 | lifeskim:mentions | umls-concept:C0019735 | lld:lifeskim |
| pubmed-article:12646688 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:12646688 | lifeskim:mentions | umls-concept:C0887819 | lld:lifeskim |
| pubmed-article:12646688 | lifeskim:mentions | umls-concept:C1704788 | lld:lifeskim |
| pubmed-article:12646688 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:12646688 | pubmed:dateCreated | 2003-3-20 | lld:pubmed |
| pubmed-article:12646688 | pubmed:abstractText | Activation of a cytotoxic T cell requires specific binding of antigenic peptides to major histocompatibility complex (MHC) molecules. This paper reports a study of peptides binding to members of the HLA-A3 superfamily using a recently developed 2D-QSAR method, called the additive method. Four alleles with high phenotype frequency were included in the study: A*0301, A*1101, A*3101 and A*6801. The influence of each of the 20 amino acids at each position of the peptide on binding was studied. A refined A3 supertype motif was defined in the study. | lld:pubmed |
| pubmed-article:12646688 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12646688 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12646688 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12646688 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12646688 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12646688 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12646688 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12646688 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12646688 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:12646688 | pubmed:issn | 0269-2139 | lld:pubmed |
| pubmed-article:12646688 | pubmed:author | pubmed-author:FlowerDarren... | lld:pubmed |
| pubmed-article:12646688 | pubmed:author | pubmed-author:DoytchinovaIr... | lld:pubmed |
| pubmed-article:12646688 | pubmed:author | pubmed-author:GuanPingpingP | lld:pubmed |
| pubmed-article:12646688 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12646688 | pubmed:volume | 16 | lld:pubmed |
| pubmed-article:12646688 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12646688 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12646688 | pubmed:pagination | 11-8 | lld:pubmed |
| pubmed-article:12646688 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:12646688 | pubmed:meshHeading | pubmed-meshheading:12646688... | lld:pubmed |
| pubmed-article:12646688 | pubmed:meshHeading | pubmed-meshheading:12646688... | lld:pubmed |
| pubmed-article:12646688 | pubmed:meshHeading | pubmed-meshheading:12646688... | lld:pubmed |
| pubmed-article:12646688 | pubmed:meshHeading | pubmed-meshheading:12646688... | lld:pubmed |
| pubmed-article:12646688 | pubmed:meshHeading | pubmed-meshheading:12646688... | lld:pubmed |
| pubmed-article:12646688 | pubmed:meshHeading | pubmed-meshheading:12646688... | lld:pubmed |
| pubmed-article:12646688 | pubmed:meshHeading | pubmed-meshheading:12646688... | lld:pubmed |
| pubmed-article:12646688 | pubmed:meshHeading | pubmed-meshheading:12646688... | lld:pubmed |
| pubmed-article:12646688 | pubmed:meshHeading | pubmed-meshheading:12646688... | lld:pubmed |
| pubmed-article:12646688 | pubmed:meshHeading | pubmed-meshheading:12646688... | lld:pubmed |
| pubmed-article:12646688 | pubmed:meshHeading | pubmed-meshheading:12646688... | lld:pubmed |
| pubmed-article:12646688 | pubmed:meshHeading | pubmed-meshheading:12646688... | lld:pubmed |
| pubmed-article:12646688 | pubmed:meshHeading | pubmed-meshheading:12646688... | lld:pubmed |
| pubmed-article:12646688 | pubmed:meshHeading | pubmed-meshheading:12646688... | lld:pubmed |
| pubmed-article:12646688 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12646688 | pubmed:articleTitle | HLA-A3 supermotif defined by quantitative structure-activity relationship analysis. | lld:pubmed |
| pubmed-article:12646688 | pubmed:affiliation | Edward Jenner Institute for Vaccine Research, Compton, Newbury, Berkshire RG20 7NN, UK. pingping.guan@jenner.ac.uk | lld:pubmed |
| pubmed-article:12646688 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12646688 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12646688 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12646688 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12646688 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12646688 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12646688 | lld:pubmed |
